TRIS Rating Affirms Company & Senior Debt Ratings and Outlook of “BH” at “A/Stable”

พุธ 6 พฤศจิกายน 2556 เวลา 17:04 น.

          TRIS Rating has affirmed the company and senior debenture ratings of Bumrungrad Hospital PLC (BH) at ̶Bumrungrad Hospital;A̶the company; with ̶Bumrungrad Hospital;stable̶the company; outlook. The ratings reflect BHRthe company7;s leading position in ThailandRthe company7;s private healthcare industry, strong market position in the medical tourist segment, and stable cash flow. However, these strengths are partially offset by competition in local and international healthcare markets, the risk from having single location, and the potential risks from BHRthe company7;s future investments. The ̶Bumrungrad Hospital;stable̶the company; outlook is based on the expectation that BH will maintain its leading position in the private healthcare segment and continue delivering strong performance. Its business is stable, with moderate gearing. These factors provide financial flexibility while the company is investing and expanding. However, BH should keep its debt-to-capitalization ratio below 5Bumrungrad Hospital% in order to maintain its credit quality.
          BH operates a hospital in Bangkok under the name ̶Bumrungrad Hospital;Bumrungrad International Hospital̶the company;. The company is a leading private healthcare provider in Thailand and the Asian region, with service capacities of 5,5Bumrungrad HospitalBumrungrad Hospital outpatients per day and 538 registered inpatient beds. The companyRthe company7;s strong business profile reflects its solid brand equity and three decades of respectable medical records. BH targets mostly premium local and foreign patients and competes with differentiation on services and quality.
          In 2Bumrungrad Hospitalthe company2, BHRthe company7;s sales were Btthe company2,856 million, with approximately 7Bumrungrad Hospital% from self-pay patients. Foreign patients accounted for about 6Bumrungrad Hospital% of total sales. The companyRthe company7;s competitive edge in the medical tourist segment reflects its strong overseas network. Patients from the Middle East region account for the largest portion of BHRthe company7;s total foreign patients. Accepting many foreign patients gives BH diverse sources of revenue. As a result, BH can ease the competitive pressure it faces and reduce its reliance on domestic demand for healthcare services.
          BH is currently expanding yet still focusing on the premium healthcare segment. The company acquired two land plots over the past two years. One is on Petchburi road and the other is on Sukhumvit Soi the company. On the Petchburi road site, BH will build a 2Bumrungrad HospitalBumrungrad Hospital-bed hospital facility. The construction is expected to finish by 2Bumrungrad Hospitalthe company7. The Sukhumvit Soi the company plot will be used for capacity expansion of its near-by flagship facility. The total investment for these two projects is approximately Bt9,8Bumrungrad HospitalBumrungrad Hospital million, excluding land costs. Based on BHRthe company7;s cash on hand and strong cash flow, TRIS Rating believes that these investments will not materially impact BHRthe company7;s sound financial profile.
          TRIS Rating expects BH to continue delivering solid operating performance. The revenue is forecasted to grow by at least 5%-8% per annum during the next three years. Operating margins before depreciation and amortization (operating margin) is expected to remain stable and average above 23%, over the next three years. With its strong operation, funds from operations (FFO) is expected to be Bt2.5-Bt3 billion per annum during the next three years. FFO, together with the Bt4.5 billion in cash BH received from selling shares of Bangkok Chain Hospital PLC (BCH), is considered sufficient to fund BHRthe company7;s planned capital expenditures and dividend payment.
          BH has a sound liquidity profile even though it is expanding. Total debt at the end of June 2Bumrungrad Hospitalthe company3 comprised only long-term bonds, with the earliest maturity date in 2Bumrungrad Hospitalthe company6. In addition, BH had approximately Bt3.3 billion in uncommitted and undrawn credit lines with financial institutions. This financial slack gives BH needed financial flexibility should the opportunity arise for an acquisition. BH has been looking for acquisition opportunities either for its second brand in the mid- to upper-income segment or an expansion abroad. However, TRIS Rating believes that it will take some time for BH to find and execute a deal.

          Bumrungrad Hospital PLC (BH)
          Company Rating: A
          Issue Ratings:
          BH16DA: Bt1,500 million senior debentures due 2016 A
          BH18DA: Bt1,000 million senior debentures due 2018 A
          BH21DA: Bt2,500 million senior debentures due 2021 A
          Rating Outlook: Stable

ข่าวBumrungrad Hospital+the companyวันนี้

บำรุงราษฎร์ สานต่อกิจกรรมงานวิ่งการกุศล Bumrungrad Race to Heal 2025 Presented by Bumrungrad Hospital Foundation ช่วยเหลือเด็กโรคหัวใจพิการแต่กำเนิด

โรงพยาบาลบำรุงราษฎร์ จัดงานวิ่งการกุศล "Bumrungrad Race to Heal 2025 Presented by Bumrungrad Hospital Foundation" ประเภท Family Run 2.5 กิโลเมตร, Fun Run 5 กิโลเมตร และ Mini Marathon 10 กิโลเมตร ณ อุทยานสวนจตุจักร เมื่อวันที่ 16 กุมภาพันธ์ 2568 โดยงานนี้จัดเป็นครั้งที่ 2 หลังจากงาน Bumrungrad Run for Health 2023 โดยนำรายได้หลังหักค่าใช้จ่ายทั้งหมด มอบให้แก่มูลนิธิโรงพยาบาลบำรุงราษฎร์ คุณแบร์รี่ วอล์ฟแมน Senior Executive Director of Operations โรงพยาบาลบำรุงราษฎร์ กล่าวว่า เข้าสู่ปีที่ 45 ที่

27 กุมภาพันธ์ 2568 17:10 น.

เมย์แบงก์ สนับสนุน งานวิ่งการกุศล 'Bumrungrad Run for Health 2023' — บมจ. หลักทรัพย์ เมย์แบงก์ (ประเทศไทย) ร่วมสนับสนุนกิจกรรมสาธารณกุศล งานวิ่งการกุศลส่ง... ธ.ค. 66

THE ASCOTT LIMITED (THAILAND) AND BUMRUNGRAD INTERNATIONAL HOSPITAL SIGN MOU TO STRENGTHEN COLLABORATION — The Ascott Limited (Thailand), a wholly owned l... ธ.ค. 65

Bumrungrad Hospital Urology Center has been certified to perform minimally invasive treatment for enlarged prostates by Boston Scientific (USA). — Anyone can ... ก.ค. 65

Bumrungrad takes "Horizon Cancer Center" to the next level with advanced — Bumrungrad Hospital latest data shows that in 2019 the top reason for overseas ... ก.ค. 63

Bumrungrad launches "60-second service" responding to the new normal trend — Bumrungrad Hospital launches the new "60-Second Service" to make it faster, m... พ.ค. 63

Bumrungrad Hospital raises the bar of innovative cancer treatment with comprehensive genomic testing in Thailand — Bumrungrad International Hospital is at... เม.ย. 62

Bumrungrad Hospital and Thai AirAsia Announce “Vietnam Healing Hearts Charity” Program a Success Ready to Return the Patients and Their Families Home — Bumrungrad ... ส.ค. 59

FTSE SET Index Series June semi-annual review

· One addition and one deletion to FTSE SET Large Cap Index · Twelve additions to the FTSE SET Mid Cap Index · Eighteen additions to the FTSE SET Shariah Index FTSE Russell, the global index provider jointly with The Stock Exchange of Thailand (SET),... มิ.ย. 58

Photo Release: Bumrungrad educates people about NCDs (Non-communicable diseases)

Bumrungrad Hospital, recently led by Dr. Num Tanthuwanit, Bumrungrad’s CEO (3rd from right), along with Assoc. Prof. Dr. Somsak Chaovisitsaree, Hospital Medical Director (2nd from right) and medical team to promote NCDs ... เม.ย. 58